UAE Catheters Market Overview, 2030

The catheter market in the UAE is influenced by significant demand from high-end private hospitals, which control the purchasing and usage across cardiovascular, urological, neurovascular, and specialized medical procedures. This market has developed in line with the country’s evolution into a medical tourism destination, where state-of-the-art hospitals in Dubai and Abu Dhabi have embraced minimally invasive techniques and top-quality devices. Catheters play vital roles such as allowing fluid drainage, providing medication delivery, and offering diagnostic access in surgical, emergency, and long-term care environments. The use of catheters surged in the early 2000s due to the growth of advanced care centers and international hospital networks. Challenges faced include strict regulatory processes, high reliance on imports, and the necessity for training medical staff. Various types include Foley, PICC, central venous, balloon dilation, and temperature-sensing catheters, each designed for specific anatomical and procedural requirements. The range of users includes hospitals, ASCs, home healthcare providers, and diagnostic laboratories. From a technical standpoint, catheters are adaptable tubes that are placed into body cavities or blood vessels to aid in drainage, infusion, or medical intervention. Within UAE clinical settings, they are utilized in cardiac mapping, stroke thrombectomy, chemotherapy delivery, and urinary management. Entry into the market is regulated by the Ministry of Health and Prevention MOHAP and the Dubai Health Authority DHA, which necessitates CE marking, ISO 13485 certification, and local representation. The premium supply is dominated by companies like Medtronic, Boston Scientific, and Edwards Lifesciences, which provide advanced coatings, user-friendly designs, and bundled kits. Key clients include private hospitals such as Cleveland Clinic Abu Dhabi, Mediclinic, and NMC, which focus on advanced catheter systems for interventional cardiology, oncology, and robotic surgical procedures.

According to the research report, "UAE Catheters Market Overview, 2030," published by Bonafide Research, the UAE Catheters market is anticipated to grow at more than 8.05% CAGR from 2025 to 2030. The catheter market in the UAE is growing consistently, influenced by top-tier healthcare facilities that focus on modern, minimally invasive technologies. Recent advancements include the endorsement of Medtronic's Symplicity Spyral Renal Denervation System and the Chocolate Touch Paclitaxel-Coated PTA Balloon Catheter, showcasing the UAE's dedication to adopting next-generation devices for treating high blood pressure and vascular conditions. Major suppliers in this field include prominent companies like Boston Scientific, Teleflex, and Edwards Lifesciences, along with local entities such as Abu Dhabi Medical Devices Company ADMD, which promotes domestic manufacturing and distribution. Medical tourism represents a significant growth opportunity, as the UAE draws patients from the Middle East, Africa, and South Asia seeking catheter-related heart, urinary, and cancer treatments. Procurement practices differ among institutions public hospitals adhere to centralized procurement through MOHAP and Emirates Drug Establishment EDE, while private hospitals negotiate directly with vendors, preferring bundled packages and contracts based on performance. Vendors are crucial in providing clinical education, monitoring after the market launch, and managing inventory, often collaborating with hospitals to create catheter procedures and ensure adherence to regulations. Major drivers of opportunity entail the increasing rates of chronic illnesses, an older population, and the UAE's initiative toward outpatient and robotic-assisted services. The segments for specialty and neurovascular catheters are experiencing the fastest growth, backed by high surgical activity and efforts in precision medicine. The importance of compliance is significant devices are required to conform to ISO 13485 standards, obtain CE marking, and register with MOHAP or DHA prior to being available in the market.

The catheter market in the UAE by product type is divided into Cardiovascular Catheters, Urological Catheters, Intravenous Catheters, Neurovascular Catheters, Infusion Catheters and Specialty Catheters & Others. Cardiovascular catheters are commonly utilized in cardiac procedures like coronary angiography, angioplasty, and valve repairs. Top hospitals such as Clemenceau Medical Center and AlSharq Hospital implement sophisticated catheter systems for less invasive treatments, including rotational atherectomy and intravascular lithotripsy. These instruments are crucial to the UAE’s programs in interventional cardiology, aligning with international standards and facilitating outpatient recovery approaches. In the realm of urology, urological catheters like Foley, intermittent, and suprapubic types are frequently used for bladder drainage, prostate treatment, and recovery after surgery. Facilities such as Right Health and NMC Healthcare provide extensive urological care, incorporating the use of catheters into both inpatient and outpatient procedures. These devices are vital for handling chronic urinary issues and aiding in the care of older patients. Intravenous catheters are widely employed in hospitals and emergency care environments for fluid replacement, medication delivery, and nutritional support. The market for IV catheters in the UAE consists of peripheral IVs, central venous catheters, and PICC lines, with an increasing trend towards the use of antimicrobial coatings and advanced infusion systems. Emergency departments in both Abu Dhabi and Dubai depend on these tools for swift intervention and critical patient care. Neurovascular catheters are used in treatments for strokes, aneurysms, and arteriovenous malformations. Institutions like Cleveland Clinic Abu Dhabi and specialized facilities in Sharjah make use of balloon guide catheters, stent retrievers, and flow diverters to ensure accurate neurosurgical procedures. This technology is essential for the growing stroke networks and neurointerventional initiatives in the UAE. Infusion catheters, which include elastomeric pumps and automated infusion devices, are employed for precise medication and fluid delivery in oncology, neonatal intensive care, and at-home healthcare.

In the UAE, catheters market by distribution channel is divided into Retail Stores, Hospital Stores and Online Stores is organized through various avenues such as pharmacies, hospital supply chains, and internet marketplaces, each with unique functions related to accessibility, purchasing, and care for patients. Pharmacies, including licensed drugstores and medical equipment shops, provide in-person access to frequently used catheter options like Foley catheters, Nelaton tubes, and suction catheters. These products are particularly vital for individuals dealing with ongoing health issues, recovering after surgery, or receiving care at home. Pharmacies located in Dubai, Abu Dhabi, and Sharjah offer both imported and locally made catheter brands, with pharmacists often aiding in product selection and offering advice on usage. The presence of retail options enhances immediate access and complements both outpatient services and home care. Hospital supply chains function within healthcare institutions, handling stock for cardiovascular, neurovascular, intravenous, and specialized catheters utilized in surgery, emergency rooms, and intensive care units. The purchasing process is managed through centralized systems in public hospitals governed by MOHAP, while private hospitals, which are prominent in the UAE's high-end healthcare sector, follow decentralized buying practices. These supply chains are responsible for inventory sterility, adherence to regulations, and operational efficiency; they often package catheter kits with necessary supplies to facilitate clinical procedures. Supply chain partners and distributors play a crucial role in keeping inventory levels stable, training healthcare personnel, and ensuring ongoing product safety monitoring. Online marketplaces are becoming more popular, providing ease of use, discretion, and wider access to products. These online platforms assist with self-catheterization, integrate telehealth services, and promote patient independence, especially among senior citizens and those with mobility challenges.

In the UAE, the catheters market by end user is divided into hospitals and ambulatory surgical centers ASCs, homecare environments, and diagnostic facilities each showcasing the country's high-end healthcare focus and increasing need for minimally invasive options. Hospitals and ASCs are the largest users, utilizing cardiovascular, neurovascular, intravenous, and specialty catheters in surgical areas, ICUs, and emergency rooms. Institutions like Cleveland Clinic Abu Dhabi, Mediclinic, and American Hospital Dubai regularly carry out catheter-based procedures for heart treatments, managing strokes, oncology infusions, and surgeries assisted by robotics. These establishments prioritize high-quality devices featuring advanced coatings, ergonomic designs, and all-in-one kits that enhance efficiency and control infections. Homecare environments are seeing a rise in the use of catheter products, especially among patients with chronic conditions and older individuals. This approach decreases hospital trips, increases patient comfort, and aids long-term management of issues like neurogenic bladder, cancer, and heart disease. Qualified nurses and mobile healthcare teams ensure safe, private, and tailored care, aligning with the UAE’s focus on decentralized healthcare and digital integration. Diagnostic facilities, such as imaging centers and interventional radiology departments, utilize catheters for delivering contrast media, mapping blood vessels, and performing targeted biopsies. Neurovascular and cardiovascular catheters play a crucial role in processes like angiography, CT-guided interventions, and endovascular assessments. These centers, often associated with tertiary hospitals or operating autonomously, play a vital role in the early detection of diseases and precise diagnostics. These user groups reflect the UAE’s changing healthcare priorities striking a balance between institutional excellence, innovative homecare, and precise diagnostics to satisfy the growing demand for safe, effective, and patient-focused catheter-based treatments.




Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Catheters Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Cardiovascular Catheters
• Urological Catheters
• Intravenous Catheters
• Neurovascular Catheters
• Infusion Catheters
• Specialty Catheters & Others (Microcatheters and Drainage & Centesis Catheters)

By Distribution Channel
• Retail Stores
• Hospital Stores
• Online Stores

By End User
• Hospitals and Ambulatory Surgical Centers (ASCs)
• Homecare Settings
• Diagnostic Centers